Ratnakar R. Bynigeri

Statistics

Publications

Citations

190

H-Index

Active since

2022

Affiliations

St. Jude Children's Research Hospital(Current)

Technology Innovation Institute

Ratnakar R. Bynigeri is an author at St. Jude Children's Research Hospital specializing in innate immunity, innate immune signaling pathways, and life sciences.

ORCID

Publications per year

2022–2024

Publications

ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL

R. K. Subbarao Malireddi, Bhesh Raj Sharma, Ratnakar R. Bynigeri et al. · Viruses · 2023 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

Raghvendra Mall, Ratnakar R. Bynigeri, Rajendra Karki et al. · NAR Cancer · 2022 · 49 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death, PANoptosis

R. K. Subbarao Malireddi, Ratnakar R. Bynigeri, Raghvendra Mall et al. · iScience · 2023 · 40 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The protein phosphatase PP6 promotes RIPK1-dependent PANoptosis

Ratnakar R. Bynigeri, R. K. Subbarao Malireddi, Raghvendra Mall et al. · BMC Biology · 2024 · 36 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets

R. K. Subbarao Malireddi, Ratnakar R. Bynigeri, Raghvendra Mall et al. · Communications Biology · 2023 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 5